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Background: Treatment of furcation defects is a core component of periodontal therapy. The goal
of this consensus report is to critically appraise the evidence and to subsequently present interpretive
conclusions regarding the effectiveness of regenerative therapy for the treatment of furcation defects
and recommendations for future research in this area.
Methods: A systematic review was conducted before the consensus meeting. This review aims to eval-
uate and present the available evidence regarding the effectiveness of different regenerative approaches for
the treatment of furcation defects in specific clinical scenarios compared with conventional surgical therapy.
During the meeting, the outcomes of the systematic review, as well as other pertinent sources of evidence,
were discussed by a committee of nine members. The consensus group members submitted additional ma-
terial for consideration by the group in advance and at the time of the meeting. The group agreed on a com-
prehensive summary of the evidence and also formulated recommendations for the treatment of furcation
defects via regenerative therapies and the conduction of future studies.
Results: Histologic proof of periodontal regeneration after the application of a combined regenerative ther-
apy for the treatment of maxillary facial, mesial, distal, and mandibular facial or lingual Class II furcation de-
fects has been demonstrated in several studies. Evidence of histologic periodontal regeneration in mandibular
Class III defects is limited to one case report. Favorable outcomes after regenerative therapy for maxillary
Class III furcation defects are limited to clinical case reports. In Class I furcation defects, regenerative therapy
may be beneficial in certain clinical scenarios, although generally Class I furcation defects may be treated
predictably with non-regenerative therapies. There is a paucity of data regarding quantifiable patient-reported
outcomes after surgical treatment of furcation defects.
Conclusions: Based on the available evidence, it was concluded that regenerative therapy is a viable op-
tion to achieve predictable outcomes for the treatment of furcation defects in certain clinical scenarios. Future
research should test the efficacy of novel regenerative approaches that have the potential to enhance the ef-
fectiveness of therapy in clinical scenarios associated historically with less predictable outcomes. Addition-
ally, future studies should place emphasis on histologic demonstration of periodontal regeneration in
humans and also include validated patient-reported outcomes.
Clinical Recommendations: Based on the prevailing evidence, the following clinical recommendations
could be offered. 1) Periodontal regeneration has been established as a viable therapeutic option for the treat-
ment of various furcation defects, among which Class II defects represent a highly predictable scenario.
Hence, regenerative periodontal therapy should be considered before resective therapy or extraction; 2)
The application of a combined therapeutic approach (i.e., barrier, bone replacement graft with or without bi-
ologics) appears to offer an advantage over monotherapeutic algorithms; 3) To achieve predictable regener-
ative outcomes in the treatment of furcation defects, adverse systemic and local factors should be evaluated
and controlled when possible; 4) Stringent postoperative care and subsequent supportive periodontal therapy
are essential to achieve sustainable long-term regenerative outcomes. J Periodontol 2015;86(Suppl.):S131-S133.
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SUMMARY OF EVIDENCE REGARDING
REGENERATIVE THERAPY FOR FURCATION
DEFECTS
The systematic review1 that preceded this consensus
report was performed to answer the following ques-
tion: in human adults with periodontal furcation in-
volvement (Class I, Class II, and/or Class III according
to Hamp et al.2), are clinical, radiographic, histologic,
microbiologic, and patient-reported outcomes im-
proved with regenerative therapy compared with non-
regenerative surgical treatment?
The group appraised the systematic review and ac-
cepted the following conclusions: 1) Periodontal re-
generation has been demonstrated histologically and
clinically for the treatment of maxillary facial, mesial,
distal, and mandibular facial or lingual Class II furcation
defects;3-5 2) Although periodontal regeneration has
been demonstrated histologically for the treatment of
mandibular Class III defects, the clinical evidence is
limited to one case report;6 3) Evidence supporting
regenerative therapy in maxillary Class III furcation
defects in molars7 and premolar furcation defects8 is
limited to clinical case reports, which reported un-
predictable outcomes; and4) InClass I furcation defects,
regenerative therapymay be beneficial in certain clinical
scenarios, although most Class I furcation defects
may be successfully treated with non-regenerative
therapy.
Additionally, the group formulated a series of treat-
ment recommendations based on current evidence: 1)
Periodontal regeneration has been established as a via-
ble therapeutic option for the treatment of various fur-
cation defects, among which Class II defects represent
a highly predictable scenario; 2) Regenerative peri-
odontal therapy should be considered before resective
therapy or extraction; 3) Based on the current state-of-
the-art reports, the application of a combined thera-
peutic approach (i.e., barrier, bone replacement graft
with or without biologics) appears to offer an advantage
over monotherapeutic algorithms; 4) To achieve pre-
dictable regenerative outcomes in the treatment of fur-
cation defects, adverse systemic and local factors should
be evaluated and controlled when possible; and 5)
Stringent postoperative care and subsequent sup-
portive periodontal therapy (maintenance) are es-
sential to achieve sustainable long-term regenerative
outcomes.
IMPLICATIONS OF REVIEW TO PATIENT-
REPORTED OUTCOMES
Based on the appraisal of the reviewed literature,
there are limited data regarding quantifiable patient-
reported outcomes. Hence, future studies should
consider oral health–related quality of life and patient
satisfaction as outcome measures.
Postoperative Pain (Short and Long Term)
Future research should focus on assessing post-
operative pain and pain management strategies to
cope with the pain. Modulating factors, such as the
operator’s experience and the patient’s psychosocial
state, such as depression, anxiety, and stress, should
be included in all assessments.
Esthetics
Typically, patient-perceived esthetics related to fur-
cation treatment is not a relevant outcome, except
for patients with a wide smile line.
Satisfaction
Future research should include patient satisfaction
assessments with a validated method, such as the
scale of treatment satisfaction by Kiyak et al.9
RESEARCH PRIORITIES FOR THE FUTURE
1) Considering the prevailing evidence for the
treatment of furcation defects identified within
this review, future research efforts should be fo-
cused on assessing emerging regenerative ap-
proaches that have the potential to enhance the
outcomes of therapy, including clinical scenar-
ios associated historically with less predictable
outcomes.
2) Investigators should also focus on the un-
derstanding of the influence that insufficiently studied
local, technical, and systemic factors, such as
metabolic disorders, have on the outcomes of re-
generative therapy for the treatment of furcation
defects.
3) Ideally, future studies should investigate non-
invasive methods to demonstrate evidence of re-
generation of the periodontal attachment apparatus
in furcation defects in humans, rather than human
histology, which is still considered the ultimate proof
of periodontal regeneration.
4) Future studies should also assess patient-reported,
advanced radiographic (i.e., three-dimensional) and
biomolecular (i.e., expression of biomarkers) out-
comes via standardized data collection protocols.
5) Future studies should include long-term results
that may guide therapeutic prognosis of teeth pre-
senting furcation defects.
6) Methodologic additions are expected to provide
critical information to better understand the effect
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that periodontal regenerative therapies have on the
quality of life of patients presenting furcation de-
fects, which will be of great value to develop cost-
effective and predictable clinical protocols.
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